It is thought that certain actions of ethanol involve an interaction with endogenous opioids,
including proopiomelanocortin‐derived pep‐tides such as β‐endorphin. To examine this …

OBJECTIVE: To explore the attitudes of family physicians (FPs) toward the use of opioids in
the management of chronic noncancer pain (CNCP) in the Calgary Health Region (CHR), …

1. Dose-response curves for angiotensins II and III in the rat isolated uterus, portal vein and
aorta, in the absence and presence of the antagonist [Sar1Ile8] ANG II, have been analyzed …

Analogues of angiotensin II and III (ANG II and ANG III) in which the tyrosine and/or
phenylalanine residues were substituted have been synthesized by the solid-phase method and …

[Sar 1 , Tyr(Me) 4 ] angiotensin II, synthesized by the solid phase method and purified by ion-exchange
chromatography and reversed-phase HPLC, was found to inhibit the contractile …

[Cys (S-acetamidomethyl) 1, 8] angiotensin II has been synthesizedby the solid-phase
method and purified by car-boxymethylcellulose chromatography and reversed-phase HPLC. …

The negative feedback control of hypothalamic cortocotrophin releasing factor (CRF) and
anterior pituitary proopiomelanocortin (POMC) by corticosteroids is well understood. However, …

Receptor blockade with the slowly dissociating angiotensin (ANG) antagonist, [Sar 1 ,Ile 8 ]ANG
II, was used to determine dissociation constants (K d ) for angiotensins II and III at …

Blockade of in vitro contractile responses to angiotensins II and III by the reversible competitive
angiotensin antagonist [Sar 1 , Tyr(Me) 4 ]ANG II (sarmesin) was investigated in 3 rat …

Abstract Treatment of rats for 4 days with α-methyldopa, 200 mg/kg/day ip, increases steady
state levels of proopiomelanocortin (POMC) mRNA in the mediobasal hypothalamus, as …